📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse. (2018)

First Author: Bonsall D

Attributed to: Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/idr.s156581

PubMed Identifier: 30127629

Publication URI: http://europepmc.org/abstract/MED/30127629

Type: Journal Article/Review

Volume: 11

Parent Publication: Infection and drug resistance

ISSN: 1178-6973